Alzheimer's disease and disseminated mycoses

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 33, Issue 7, 2014, Pages 1125-1132

  Alonso, R ^a   Pisa, D ^a   Rabano A ^b   Carrasco, L ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

FUNGAL POLYSACCHARIDE; FUNGUS ANTIBODY; BETA GLUCAN; BETA-1,3-D-GLUCAN;

AGED; ALZHEIMER DISEASE; ANTIBODY BLOOD LEVEL; ARTICLE; CANDIDA ALBICANS; CANDIDA FAMATA; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CROSS REACTION; HUMAN; HUMAN TISSUE; HUMORAL IMMUNITY; IMMUNOREACTIVITY; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR; SEROPREVALENCE; SYSTEMIC MYCOSIS; VERY ELDERLY; ZYGOMYCETES; BLOOD; COMPLICATION; FEMALE; MALE; MYCOSES; PREVALENCE;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANTIBODIES, FUNGAL; BETA-GLUCANS; FEMALE; HUMANS; MALE; MYCOSES; PREVALENCE;

EID: 84903817317     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-013-2045-z     Document Type: Article

References (44)

1. Blennow K, de Leon MJ, Zetterberg H (2006) Alzheimer's disease. Lancet Neurol 368:387-403 (Pubitemid 44108123)
2. Claeysen S, Cochet M, Donneger R, Dumuis A, Bockaert J, Giannoni P (2012) Alzheimer culprits: cellular crossroads and interplay. Cell Signal 24(9):1831-1840
3. Mayeux R, Stern Y (2012) Epidemiology of Alzheimer disease. Cold Spring Harb Perspect Med 2(8):a006239
4. Bagger YZ, Tanko LB, Alexandersen P, Qin G, Christiansen C (2004) The implications of body fat mass and fat distribution for cognitive function in elderly women. Obes Res 12(9):1519-1526 (Pubitemid 41137458)
5. Barberger-Gateau P, Raffaitin C, Letenneur L, Berr C, Tzourio C, Dartigues JF, Alperovitch A (2007) Dietary patterns and risk of dementia: the Three-City cohort study. Neurol 69(20):1921-1930 (Pubitemid 350100350)
6. Shah R (2013) The role of nutrition and diet in Alzheimer disease: a systematic review. J Am Med Dir Assoc 14(6):398-402
7. Vignini A, Giulietti A, Nanetti L, Raffaelli F, Giusti L, Mazzanti L, Provinciali L (2013) Alzheimer's disease and diabetes: new insights and unifying therapies. Curr Diabetes Rev 9(3):218-227
8. O'Brien RJ, Wong PC (2011) Amyloid precursor protein processing and Alzheimer's disease. Annu Rev Neurosci 34:185-204
9. Revett TJ, Baker GB, Jhamandas J, Kar S (2012) Glutamate system, amyloid ss peptides and tau protein: functional interrelationships and relevance to Alzheimer disease pathology. J Psychiatry Neurosci 38(1):6-23
10. Tanzi RE (2005) The synaptic Abeta hypothesis of Alzheimer disease. Nat Neurosci 8(8):977-979
11. Teich A, Arancio O (2012) Is the amyloid hypothesis of Alzheimer's disease therapeutically relevant? Biochem J 446(2):165-177
12. Itzhaki RF, Lin WR, Shang D, Wilcock GK, Faragher B, Jamieson GA (1997) Herpes simplex virus type 1 in brain and risk of Alzheimer's disease. Lancet 349(9047):241-244 (Pubitemid 27050990)
13. Itzhaki RF, Wozniak MA, Appelt DM, Balin BJ (2004) Infiltration of the brain by pathogens causes Alzheimer's disease. Neurobiol Aging 25(5):619-627 (Pubitemid 38686484)
14. Kountouras J, Tsolaki M, Gavalas E, Boziki M, Zavos C, Karatzoglou P, Chatzopoulos D, Venizelos I (2006) Relationship between helicobacter pylori infection and Alzheimer disease. Neurol 66(6):938-940 (Pubitemid 43739779)
15. Miklossy J, Kis A, Radenovic A, Miller L, Forro L, Martins R, Reiss K, Darbinian N, Darekar P, Mihaly L, Khalili K (2006) Beta-amyloid deposition and Alzheimer's type changes induced by Borrelia spirochetes. Neurobiol Aging 27(2):228-236 (Pubitemid 43038546)
16. Urosevic N, Martins RN (2008) Infection and Alzheimer's disease: the APOE epsilon4 connection and lipid metabolism. J Alzheimers Dis 13(4):421-435 (Pubitemid 352039025)
17. Ala TA, Doss RC, Sullivan CJ (2004) Reversible dementia: a case of cryptococcal meningitis masquerading as Alzheimer 's disease. J Alzheimers Dis 6(5):503-508 (Pubitemid 40921721)
18. Hoffmann M, Muniz J, Carroll E, De Villasante J (2009) Cryptococcal meningitis misdiagnosed as Alzheimer 's disease: complete neurological and cognitive recovery with treatment. J Alzheimers Dis 16(3):517-520
19. Benito-Leon J, Pisa D, Alonso R, Calleja P, Diaz-Sanchez M, Carrasco L (2010) Association between multiple sclerosis and Candida species: evidence from a case-control study. Eur J Clin Microbiol Infect Dis 29(9):1139-1145
20. Carrasco L, Ramos M, Galisteo R, Pisa D, Fresno M, Gonzalez ME (2005) Isolation of Candida famata from a patient with acute zonal occult outer retinopathy. J Clin Microbiol 43(2):635-640 (Pubitemid 40256012)
21. Pisa D, Alonso R, Carrasco L (2011) Fungal infection in a patient with multiple sclerosis. Eur J Clin Microbiol Infect Dis 30(10):1173-1180
22. Pisa D, Alonso R, Jimenez-Jimenez FJ, Carrasco L (2013) Fungal infection in cerebrospinal fluid from some patients with multiple sclerosis. Eur J Clin Microbiol Infect Dis 32(6):795-801
23. Pisa D, Ramos M, Garcia P, Escoto R, Barraquer R, Molina S, Carrasco L (2008) Fungal infection in patients with serpiginous choroiditis or acute zonal occult outer retinopathy. J Clin Microbiol 46(1):130-135
24. Martinez-Martin P, Avila J (2010) Alzheimer Center Reina Sofia Foundation: fighting the disease and providing overall solutions. J Alzheimers Dis 21(2):337-348
25. Pazos C, Ponton J, Del Palacio A (2005) Contribution of (1->3)-beta-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan. J Clin Microbiol 43(1):299-305 (Pubitemid 40096315)
26. Lamoth F, Cruciani M, Mengoli C, Castagnola E, Lortholary O, Richardson M, Marchetti O (2012) beta-Glucan antigenemia assay for the diagnosis of invasive fungal infections in patients with hematological malignancies: a systematic review and meta-analysis of cohort studies from the Third European Conference on Infections in Leukemia (ECIL-3). Clin Infect Dis 54(5):633-643
27. Ostrosky-Zeichner L (2012) Invasive mycoses: diagnostic challenges. Am J Med 125(1 Suppl):S14-S24
28. Obayashi T, Yoshida M, Tamura H, Aketagawa J, Tanaka S, Kawai T (1992) Determination of plasma (1→3)-beta-D-glucan: a new diagnostic aid to deep mycosis. J Med Vet Mycol 30(4):275-280
29. White PL, Perry MD, Barnes RA (2009) An update on the molecular diagnosis of invasive fungal disease. FEMS Microbiol Lett 296(1):1-10
30. Bateman RJ, Siemers ER, Mawuenyega KG, Wen G, Browning KR, Sigurdson WC, Yarasheski KE, Friedrich SW, Demattos RB, May PC, Paul SM, Holtzman DM (2009) A gamma-secretase inhibitor decreases amyloid-beta production in the central nervous system. Ann Neurol 66(1):48-54
31. Salloway S, Sperling R, Keren R, Porsteinsson AP, van Dyck CH, Tariot PN, Gilman S, Arnold D, Abushakra S, Hernandez C, Crans G, Liang E, Quinn G, Bairu M, Pastrak A, Cedarbaum JM (2011) A phase 2 randomized trial of ELND005, scyllo-inositol, in mild to moderate Alzheimer disease. Neurology 77(13):1253-1262
32. Papareddy P, Morgelin M, Walse B, Schmidtchen A, Malmsten M (2012) Antimicrobial activity of peptides derived from human ss-amyloid precursor protein. J Pept Sci 18(3):183-191
33. Soscia SJ, Kirby JE, Washicosky KJ, Tucker SM, Ingelsson M, Hyman B, Burton MA, Goldstein LE, Duong S, Tanzi RE, Moir RD (2010) The Alzheimer 's disease-associated amyloid beta-protein is an antimicrobial peptide. PloS one 5(3):e9505
34. Reis HJ, Mukhamedyarov MA, Rizvanov AA, Palotas A (2010) A new story about an old guy: is Alzheimer 's disease infectious? Neurodegener Dis 7(4):272-278
35. Butchart J, Holmes C (2012) Systemic and central immunity in Alzheimer's disease: therapeutic implications. CNS Neurosci Ther 18(1):64-76
36. Goldgaber D, Harris HW, Hla T, Maciag T, Donnelly RJ, Jacobsen JS, Vitek MP, Gajdusek DC (1989) Interleukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells. Proc Natl Acad Sci USA 86(19):7606-7610 (Pubitemid 19254505)
37. Sutinen EM, Pirttila T, Anderson G, Salminen A, Ojala JO (2012) Pro-inflammatory interleukin-18 increases Alzheimer 's disease-associated amyloid-beta production in human neuron-like cells. J Neuroinflammation 9:199
38. Wuthrich M, Deepe GS Jr, Klein B (2012) Adaptive immunity to fungi. Annu Rev Immunol 30:115-148
39. Borenstein AR, Wu Y, Mortimer JA, Schellenberg GD, McCormick WC, Bowen JD, McCurry S, Larson EB (2005) Developmental and vascular risk factors for Alzheimer's disease. Neurobiol Aging 26(3):325-334 (Pubitemid 40082715)
40. Deramecourt V, Slade JY, Oakley AE, Perry RH, Ince PG, Maurage CA, Kalaria RN (2012) Staging and natural history of cerebrovascular pathology in dementia. Neurology 78(14):1043-1050
41. Gorelick PB, Scuteri A, Black SE, Decarli C, Greenberg SM, Iadecola C, Launer LJ, Laurent S, Lopez OL, Nyenhuis D, Petersen RC, Schneider JA, Tzourio C, Arnett DK, Bennett DA, Chui HC, Higashida RT, Lindquist R, Nilsson PM, Roman GC, Sellke FW, Seshadri S (2011) Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 42(9):2672-2713
42. Kalaria R (2002) Similarities between Alzheimer's disease and vascular dementia. J Neurol Sci 203:29-34
43. Kalaria R, Akinyemi R, Ihara M (2012) Does vascular pathology contribute to Alzheimer changes? J Neurol Sci 322(1-2):141-147
44. Liu CC, Kanekiyo T, Xu H, Bu G (2013) Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat Rev Neurol 9(2):106-118